Detalhe da pesquisa
1.
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Lancet Oncol
; 25(5): e193-e204, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697165
2.
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.
BMC Cancer
; 24(1): 171, 2024 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310262
3.
Stereotactic ablative radiotherapy before resection to avoid delay for early-stage lung cancer or oligometastases during the COVID-19 pandemic: Pathologic outcomes from the SABR-BRIDGE protocol.
Cancer
; 129(18): 2798-2807, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221679
4.
Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR).
BMC Cancer
; 22(1): 468, 2022 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35484614
5.
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial.
BMC Cancer
; 22(1): 746, 2022 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804307
6.
DART: diagnostic-CT-enabled planning: a randomized trial in palliative radiation therapy (study protocol).
BMC Palliat Care
; 21(1): 220, 2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482335
7.
Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy.
BMC Cancer
; 21(1): 405, 2021 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33853550
8.
Opioid therapy vs. multimodal analgesia in head and neck Cancer (OPTIMAL-HN): study protocol for a randomized clinical trial.
BMC Palliat Care
; 20(1): 45, 2021 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740977
9.
Artificial Intelligence in Lung Cancer: Bridging the Gap Between Computational Power and Clinical Decision-Making.
Can Assoc Radiol J
; 72(1): 86-97, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735493
10.
Utilizing Artificial Intelligence for Head and Neck Cancer Outcomes Prediction From Imaging.
Can Assoc Radiol J
; 72(1): 73-85, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735452
11.
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.
Lancet
; 393(10185): 2051-2058, 2019 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982687
12.
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
BMC Cancer
; 20(1): 380, 2020 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32370765
13.
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.
BMC Cancer
; 20(1): 125, 2020 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32059705
14.
Local Ablative Therapies in Oligometastatic NSCLC: New Data and New Directions.
Semin Respir Crit Care Med
; 41(3): 369-376, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32450591
15.
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
Lancet Oncol
; 20(10): 1349-1359, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31416685
16.
Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial.
BMC Cancer
; 19(1): 1206, 2019 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31829203
17.
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
BMC Cancer
; 19(1): 816, 2019 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31426760
18.
Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy.
Acta Oncol
; 56(4): 548-554, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28358667
19.
Should stereotactic ablative body radiotherapy be the standard of care in oligometastatic cancer?
Lancet Oncol
; 22(1): 6-8, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387496
20.
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.
Lancet Oncol
; 17(12): 1672-1682, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789196